Resmed Inc. buy Royal Bank of Canada
Start price
01.08.25
/
50%
€241.30
Target price
01.08.26
€262.86
Performance (%)
-10.53%
Price
02.12.25
€215.90
Summary
This prediction is currently active. The prediction for Resmed Inc. disappoints with a performance of -10.53%. This prediction currently runs until 01.08.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Resmed Inc. | -2.396% | -2.396% |
| iShares Core DAX® | 0.697% | -0.987% |
| iShares Nasdaq 100 | 1.661% | -1.837% |
| iShares Nikkei 225® | 0.922% | -7.458% |
| iShares S&P 500 | 0.430% | -0.851% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) had its price target raised by analysts at Royal Bank Of Canada from $294.00 to $300.00. They now have an "outperform" rating on the stock.
Ratings data for RMD provided by MarketBeat